Have a personal or library account? Click to login
Multiple Organ Dysfunction Secondary to Herpes Simplex Virus -1 Reactivation After Treatment With Dexamethasone and Sarilumab for Covid-19 Disease Cover

Multiple Organ Dysfunction Secondary to Herpes Simplex Virus -1 Reactivation After Treatment With Dexamethasone and Sarilumab for Covid-19 Disease

Open Access
|May 2023

Figures & Tables

Fig. 1.

Timeline of events throughout ICU admission. A. Biochemical results (CRP and Creatinine), B. Microbiology results, C. treatments (Blue: bacterial/antibiotic, Green: fungal/antifungal, Orange: viral/antiviral). D. Organ support: controlled mechanical ventilation (continuous line), proning (thick line), pressure support (dash line), and tracheostomy mask (dotted line). Cardiovascular support: noradrenaline infusion. Renal support: CRRT.
Timeline of events throughout ICU admission. A. Biochemical results (CRP and Creatinine), B. Microbiology results, C. treatments (Blue: bacterial/antibiotic, Green: fungal/antifungal, Orange: viral/antiviral). D. Organ support: controlled mechanical ventilation (continuous line), proning (thick line), pressure support (dash line), and tracheostomy mask (dotted line). Cardiovascular support: noradrenaline infusion. Renal support: CRRT.

Fig. 2.

Progression of facial rash A) day 8, B) day 17, and C) Day 30
Progression of facial rash A) day 8, B) day 17, and C) Day 30

Fig. 3.

Chest x-rays from A) day 8, B) day 17, and C) Day 30. D) Computed tomography pulmonary angiogram on day 9 demonstrating widespread ground glass appearances consistent with COVID pneumonitis.
Chest x-rays from A) day 8, B) day 17, and C) Day 30. D) Computed tomography pulmonary angiogram on day 9 demonstrating widespread ground glass appearances consistent with COVID pneumonitis.

Severity scores on admission, ogan support parameters and biochemical test values at key stages throughout ICU admission

TestAdmissionDay 7Day 17: HSV-1 PositiveDay 28: Completion of AcyclovirDay 49: ICU Discharge
Severity ScoreMODS8N/AN/AN/AN/A
SOFA8N/AN/AN/AN/A
APACHE-II14N/AN/AN/AN/A
Respiratory SupportFiO2 (%)6035703521
PEEP (cmH20)1616158N/A
Pressure Support (cmH20)N/AN/AN/A15N/A
Mode of VentilationVolume ControlVolume ControlVolume ControlPressure SupportNo Support
Cardiovascular SupportNoradrenaline dose (mcg/kg/hour)000.0300
Renal SupportFiltration Rate (ml/kg/hr)002500
Laboratory FindingsHb (g/L)14210810090110
PLT (×109/L)209216171231237
WCC (×109/L)8.25.410.310.17.5
Neutrophils (×109/L)7.33.97.17.44.7
Lymphocytes(×109/L)0.61.321.72.3
PT (seconds)12.913.414.315.9N/A
APTT (seconds)28.923.629.731.1N/A
INR1.01.11.11.1N/A
Urea (mmol/L)3.41111.75.63.3
Creatinine (μmol/L)67571014748
eGFR (ml/min/1.73m2)>90>9058>90>90
Na+ (mmol/L)136143144141137
K+ (mmol/L)4.244.24.13.1
ALT (iu/L)5373443329
ALP (iu/L)5847646163
Bilirubin (μmol/L)91014108
Albumin (g/L)3931313034
CRP6381213711
pH7.47.547.417.45N/A
Lactate (mmol/L)1.61.81.71.6N/A
pO2 (kPa)9.78.712.68.7N/A
pCO2 (kPa)5.76.48.35.1N/A
DOI: https://doi.org/10.2478/jccm-2023-0010 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Language: English
Page range: 122 - 128
Submitted on: Aug 18, 2022
Accepted on: Feb 8, 2023
Published on: May 8, 2023
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2023 Thomas Roe, Sam Waddy, Nikitas Nikitas, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.